Aptima® Chlamydia trachomatis Assay
FDA 510(k) K230451 · Hologic, Inc.
510(k) numberK230451
Submission
- Device name
- Aptima® Chlamydia trachomatis Assay
- Applicant
- Hologic, Inc.
San Diego, CA, US - Received
- February 21, 2023
- Decision date
- November 16, 2023
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- MKZ – Dna Probe, Nucleic Acid Amplification, Chlamydia
- Device class
- Class I (low risk)
- Regulation
- 21 CFR 866.3120
- Specialty
- Microbiology
Other 510(k)s with product code MKZ
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K140446 | BD Probetec Chlamydia Trachomatis (CT) QX Amplified DNA AssayMKZ · Traditional | Becton, Dickinson & CO | 05/20/2014SE |
| K110923 | Cobas 4800 CT / NG TestMKZ · Traditional | Roche Molecular Systems, Inc. | 01/24/2012SE |
| K091724 | BD Probetec Chlamydia Trachomatis (CT) Q Amplified DNA AssayMKZ · Traditional | Becton, Dickinson & CO | 11/13/2009SE |
| K090824 | BD Probetec Chlamydia Trachomatis (CT) QX Amplified DNA AssayMKZ · Traditional | Becton, Dickinson & CO | 06/02/2009SE |
| K081824 | BD Probetec Chlamydia Trachomatis (CT) Q Amplified DNA AssayMKZ · Traditional | Becton, Dickinson & CO | 12/11/2008SE |
| K080739 | Abbott Realtime Ct/Ng Assay and Multi-Collect Specimen Collection KitMKZ · Traditional | Abbott Molecular, Inc. | 07/10/2008SE |
| K070174 | Amplicor Ct/Ng Test for Chlamydia Trachomatis; Roche Scripts for Ct/Ng Test AccessoryMKZ · Traditional | Roche Diagnostics Corporation | 04/16/2007SE |
| K063451 | Gen-Probe Aptima Assay for Chlamydia Trachomatis, Model 1199MKZ · Traditional | Gen-Probe, Inc. | 01/22/2007SE |
| K061413 | Aptima CT Assay on the Tigris DTS SystemMKZ · Traditional | Gen-Probe, Inc. | 10/13/2006SE |
| K053287 | Cobas Amplicor Ct/Ng Test for Chlamydia TrachomatisMKZ · Traditional | Roche Diagnostics Corp. | 08/10/2006SE |
More from Roche Diagnostics Corp.
| 510(k) | Device | Decision |
|---|---|---|
| K254090 | I-View®MUE · Traditional | 09/02/2026SE |
| K262792 | Brevera Biopsy System with CorLumina Imaging Technology (BREVDISP09)KNW · Special | 08/12/2026SE |
| K253634 | CoolSeal Generator® (CSL-200-90)GEI · Traditional | 06/17/2026SE |
| K251993 | Panther Fusion GI Expanded Bacterial AssayPCH · Traditional | 09/25/2025SE |
| K251868 | Panther Fusion GI Bacterial AssayPCH · Traditional | 09/25/2025SE |
| K243341 | Genius AI Detection 2.0QDQ · Traditional | 07/31/2025SE |
| K243396 | Aptima SARS-CoV-2 AssayQQX · Traditional | 02/13/2025SE |
| K243935 | Aptima CMV Quant AssayPAB · Special | 01/17/2025SE |
| K243345 | Aptima BV Assay; Aptima CV/TV AssayPQA · Special | 11/25/2024SE |
| K242465 | Panther Fusion SARS-CoV-2/Flu A/B/RSV assayQOF · Traditional | 11/15/2024SE |
Questions and answers
When was Aptima® Chlamydia trachomatis Assay cleared by the FDA?
Aptima® Chlamydia trachomatis Assay (K230451) received a 510(k) decision of Substantially Equivalent on November 16, 2023, 268 days after the submission was received.
What is the product code of K230451?
The FDA product code is MKZ – Dna Probe, Nucleic Acid Amplification, Chlamydia, a Class I (low risk) device regulated under 21 CFR 866.3120.